Geron Corporation (GERN): Price and Financial Metrics

GERN POWR Grades

• Sentiment is the dimension where GERN ranks best; there it ranks ahead of 61.41% of US stocks.
• GERN's strongest trending metric is Growth; it's been moving down over the last 52 weeks.
• GERN's current lowest rank is in the Value metric (where it is better than 12.76% of US stocks).

GERN Stock Summary

• Geron Corp's capital turnover -- a measure of revenue relative to shareholder's equity -- is better than merely 6.68% of US listed stocks.
• With a price/sales ratio of 1,164.37, Geron Corp has a higher such ratio than 99.41% of stocks in our set.
• With a year-over-year growth in debt of 581.46%, Geron Corp's debt growth rate surpasses 97.69% of about US stocks.
• Stocks that are quantitatively similar to GERN, based on their financial statements, market capitalization, and price volatility, are ARDS, CKPT, ATNM, MCRB, and CLLS.
• Visit GERN's SEC page to see the company's official filings. To visit the company's web site, go to www.geron.com.

GERN Valuation Summary

• GERN's price/sales ratio is 1156.5; this is 30334.21% higher than that of the median Healthcare stock.
• Over the past 243 months, GERN's price/sales ratio has gone up 1098.9.
• GERN's EV/EBIT ratio has moved up 6.1 over the prior 243 months.

Below are key valuation metrics over time for GERN.

GERN Growth Metrics

• Its year over year revenue growth rate is now at -25.71%.
• Its 2 year price growth rate is now at -55.65%.
• Its year over year net cashflow from operations growth rate is now at -27.77%.

Over the past 67 months, GERN's revenue has gone down $35,969,000.

The table below shows GERN's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2021-06-30	0.402	-78.611	-100.836
2021-03-31	0.338	-73.192	-87.086
2020-12-31	0.253	-66.652	-75.617
2020-09-30	0.374	-64.404	-80.9
2020-06-30	0.397	-60.935	-76.429
2020-03-31	0.455	-57.285	-74.844

GERN's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• GERN has a Quality Grade of C, ranking ahead of 51.69% of graded US stocks.
• GERN's asset turnover comes in at 0.002 -- ranking 425th of 681 Pharmaceutical Products stocks.
• ZTS, NSTG, and NEOG are the stocks whose asset turnover ratios are most correlated with GERN.

The table below shows GERN's key quality metrics over time.